ArticleThe Journal of international medical research2023

Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation.

Dung Thi Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.